HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

You-Jin Jeon Selected Research

Atrophy

2/2024Exploring the Potential of Crassostrea nippona Hydrolysates as Dietary Supplements for Mitigating Dexamethasone-Induced Muscle Atrophy in C2C12 Cells.
9/2023Exploring the Potential of Olive Flounder Processing By-Products as a Source of Functional Ingredients for Muscle Enhancement.
3/2022Diphlorethohydroxycarmalol Derived from Ishige okamurae Improves Behavioral and Physiological Responses of Muscle Atrophy Induced by Dexamethasone in an In-Vivo Model.
10/2021Zebrafish Model for Studying Dexamethasone-Induced Muscle Atrophy and Preventive Effect of Maca (Lepidium meyenii).
10/2020Diphlorethohydroxycarmalol (DPHC) Isolated from the Brown Alga Ishige okamurae Acts on Inflammatory Myopathy as an Inhibitory Agent of TNF-α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


You-Jin Jeon Research Topics

Disease

34Inflammation (Inflammations)
02/2024 - 09/2006
20Neoplasms (Cancer)
04/2023 - 06/2006
10Body Weight (Weight, Body)
04/2023 - 06/2012
8Melanoma (Melanoma, Malignant)
08/2023 - 01/2012
8Obesity
04/2023 - 05/2013
7Muscular Atrophy (Muscle Atrophy)
02/2024 - 10/2020
7Hyperglycemia
07/2019 - 08/2009
6Insulin Resistance
03/2019 - 07/2011
5Atrophy
02/2024 - 10/2020
5Hypertension (High Blood Pressure)
05/2022 - 10/2017
5Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 11/2013
5Asthma (Bronchial Asthma)
10/2020 - 03/2008
4Bone Resorption
02/2022 - 12/2017
4Neoplasm Metastasis (Metastasis)
02/2021 - 09/2006
4Fatty Liver
10/2020 - 06/2012
4Type 2 Diabetes Mellitus (MODY)
10/2017 - 03/2012
4Leukemia
01/2016 - 06/2010
3Hypertrophy
02/2024 - 01/2022
3Glucose Intolerance
01/2021 - 05/2016
3Colonic Neoplasms (Colon Cancer)
01/2015 - 06/2006
3Respiratory Hypersensitivity
12/2011 - 03/2008
2Sarcopenia
02/2024 - 08/2022
2Respiratory Tract Diseases (Respiratory Tract Disease)
11/2023 - 01/2021
2Atopic Dermatitis (Atopic Eczema)
09/2022 - 08/2020
2Breast Neoplasms (Breast Cancer)
03/2022 - 03/2015
2Arthritis (Polyarthritis)
11/2021 - 09/2006
2Infections
11/2021 - 07/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2021 - 05/2009
2Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 04/2019
2Edema (Dropsy)
06/2021 - 08/2020
2Hepatocellular Carcinoma (Hepatoma)
02/2021 - 10/2013
2Pneumonia (Pneumonitis)
01/2021 - 03/2020
2Colitis
10/2020 - 10/2012
2Osteoporosis
09/2020 - 11/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
06/2020 - 10/2019
2Anaphylaxis (Anaphylactic Shock)
01/2020 - 12/2015

Drug/Important Bio-Agent (IBA)

13Particulate MatterIBA
12/2023 - 01/2019
12dieckolIBA
06/2021 - 05/2009
10CytokinesIBA
12/2022 - 03/2008
9Proteins (Proteins, Gene)FDA Link
02/2024 - 10/2013
9fucoidanIBA
02/2024 - 12/2017
9Ethanol (Ethyl Alcohol)IBA
11/2023 - 12/2011
8AntioxidantsIBA
12/2022 - 05/2013
8Glucose (Dextrose)FDA LinkGeneric
10/2019 - 07/2011
6Melanins (Melanin)IBA
08/2023 - 01/2012
6PolyphenolsIBA
04/2023 - 07/2006
6Immunoglobulin E (IgE)IBA
01/2020 - 03/2008
5Dexamethasone (Maxidex)FDA LinkGeneric
02/2024 - 10/2021
5LipopolysaccharidesIBA
02/2024 - 09/2017
5EnzymesIBA
11/2023 - 07/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2021 - 03/2008
5Blood Glucose (Blood Sugar)IBA
07/2019 - 07/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 02/2012
4Polysaccharides (Glycans)IBA
08/2023 - 01/2015
4alpha-MSHIBA
08/2023 - 09/2013
4LipidsIBA
04/2023 - 05/2017
4Triglycerides (Triacylglycerol)IBA
09/2022 - 04/2016
4Antihypertensive Agents (Antihypertensives)IBA
05/2022 - 05/2013
4diphlorethohydroxycarmalolIBA
03/2022 - 08/2009
4AllergensIBA
12/2021 - 03/2008
4Insulin (Novolin)FDA Link
10/2020 - 03/2013
4OvalbuminIBA
10/2020 - 03/2008
4Melanocyte-Stimulating Hormones (MSH)IBA
09/2020 - 09/2013
4octaphlorethol AIBA
04/2015 - 05/2013
3AlginatesIBA
08/2023 - 12/2020
3Toll-Like Receptors (Toll-Like Receptor)IBA
12/2022 - 03/2020
3Mitogen-Activated Protein KinasesIBA
12/2022 - 03/2013
3bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
11/2021 - 10/2019
3Matrix Metalloproteinases (MMPs)IBA
11/2021 - 09/2006
3fucoxanthinIBA
01/2021 - 09/2010
3Caspase 3 (Caspase-3)IBA
06/2020 - 06/2010
3Monophenol Monooxygenase (Tyrosinase)IBA
01/2020 - 01/2012
3Peptides (Polypeptides)IBA
12/2014 - 10/2012
3GlucosidasesIBA
10/2014 - 10/2010
3Streptozocin (Streptozotocin)FDA Link
09/2013 - 08/2009
3Phenobarbital (Luminal)FDA Link
12/2011 - 03/2008
2Pepsin A (Pepsin)IBA
12/2023 - 10/2012
2Subtilisins (Subtilopeptidase A)IBA
11/2023 - 01/2015
2Gallic AcidIBA
11/2023 - 03/2015
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2022 - 02/2012
2Therapeutic UsesIBA
12/2022 - 03/2019
2Dinoprostone (PGE2)FDA Link
12/2022 - 01/2012
2CosmeceuticalsIBA
12/2022 - 06/2020
2NF-kappa B (NF-kB)IBA
12/2022 - 06/2006
2Dinitrochlorobenzene (DNCB)IBA
09/2022 - 08/2020
2Muscle Proteins (Muscle Protein)IBA
04/2022 - 10/2020
2ishophloroglucin AIBA
04/2022 - 09/2020
2saringosterolIBA
03/2022 - 02/2021
2Acetates (Acetic Acid Esters)FDA Link
03/2022 - 02/2021
2PhloroglucinolIBA
06/2021 - 07/2010
2loliolideIBA
05/2021 - 02/2021
2InterferonsIBA
05/2021 - 10/2020
2fucosterolIBA
12/2020 - 01/2019
2InterleukinsIBA
10/2020 - 11/2019
2Dextran SulfateIBA
10/2020 - 10/2012
2eckolIBA
01/2020 - 03/2008
2Anti-Allergic Agents (Antiallergic Agents)IBA
01/2020 - 09/2016

Therapy/Procedure

8Oral Administration
11/2023 - 03/2015
4Therapeutics
12/2014 - 03/2008
2Ovariectomy (Oophorectomy)
09/2020 - 11/2019